Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD45RB expression defines two interconvertible subsets of human CD4+ T cells with memory function

K J Horgan1, Y Tanaka, G E Luce

  • 1Experimental Immunology Branch, NCI, NIH, Bethesda, MD 20892.

European Journal of Immunology
|May 1, 1994
PubMed
Summary

Two subsets of human CD4+ T memory cells (CD45RA-CD45RO+) were identified based on CD45RB expression: MEM 1 (CD45RBbright) and MEM 2 (CD45RBintermediate). MEM 1 cells show greater interferon-gamma production and proliferation, suggesting CD45RB fine-tunes memory cell responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are MHC class II-restricted cytotoxic T lymphocytes important?

Immunology today·2014
Same author

Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells.

Scandinavian journal of immunology·2007
Same author

Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2006
Same author

The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.

European journal of cancer (Oxford, England : 1990)·2004
Same author

Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Same author

Small intestinal submucosa induces loss of mitochondrial integrity and caspase-dependent apoptosis in human T cells.

Tissue engineering·2003

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Human CD4+ T cells differentiate into naive (CD45RA+CD45RO-) and memory (CD45RA-CD45RO+) populations.
  • Two distinct memory CD4+ T cell subsets, MEM 1 (CD45RO+RBbright) and MEM 2 (CD45RO+RBintermediate), were identified based on CD45RB isoform expression levels.

Purpose of the Study:

  • To investigate the functional properties and potential interconversion of CD45RBbright and CD45RBintermediate memory CD4+ T cell subsets.
  • To determine if differential CD45RB expression influences cytokine production and proliferative capacity of memory T cells.

Main Methods:

  • Flow cytometry was used to distinguish CD4+ T cell subsets based on CD45RA, CD45RO, and CD45RB expression.
  • In vitro activation assays were performed to assess T cell proliferation and cytokine (IL-2, IL-4, IL-5, IFN-gamma) production.

Related Experiment Videos

Main Results:

  • Both MEM 1 and MEM 2 subsets proliferated in response to recall antigens.
  • Activated MEM 1 cells tended to down-regulate CD45RB, while activated MEM 2 cells tended to up-regulate it, indicating potential interconversion.
  • MEM 1 cells exhibited significantly higher proliferation (2.3-fold) and slightly greater IFN-gamma production (1.7-fold) compared to MEM 2 cells.

Conclusions:

  • Differential CD45RB expression defines functionally distinct memory CD4+ T cell subsets (MEM 1 and MEM 2).
  • The labile nature of CD45RB expression suggests a mechanism for dynamic regulation of memory T cell responses in vivo.
  • CD45RB expression variability may fine-tune the responsiveness of memory T cells.